Comprehensive analysis of common coding sequence variants in Taiwanese Han population  by Lin, Ya-Chi et al.
Biomarkers and Genomic Medicine (2014) 6, 133e143Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.j -bgm.comORIGINAL ARTICLEComprehensive analysis of common coding
sequence variants in Taiwanese Han
population
Ya-Chi Lin a,e,f, Joseph T. Tseng b,e, Shuen-Lin Jeng c,
H. Sunny Sun d,e,f,*a Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan
b Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology,
National Cheng Kung University, Tainan, Taiwan
c Department of Statistics, National Cheng Kung University, Tainan, Taiwan
d Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
e Center for Genomic Medicine, National Cheng Kung University, Tainan, Taiwan
f Bioinformatics Center, National Cheng Kung University, Tainan, TaiwanReceived 7 March 2014; received in revised form 12 May 2014; accepted 16 May 2014
Available online 24 June 2014KEYWORDS
exome sequencing;
loss-of-function;
molecular medicine;
population genetics;
sequence variants* Corresponding author. Institute o
Tainan 70101, Taiwan.
E-mail address: hssun@mail.ncku.e
http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2014, TaiwanAbstract The diversity of genomic variations exists among different ethnic populations. In-
formation on population-specific genomic variants provides important insights to link between
genotypes and phenotypes. To facilitate genomic medicine research, this study aims to detect
and characterize sequence variations enriched in the coding regions of the genome in the Chi-
nese population residing in Taiwan. DNAs from 11 unrelated Taiwanese individuals were en-
riched for coding regions (i.e., exome) and followed by deep sequencing. Approximately
30 Gb of high-quality data from massively parallel sequencing was obtained. On average,
w60% of the total reads were uniquely mapped to the human reference genome and overall
97% of the target regions were covered by sequence reads, resulting in an average enrichment
fold relative to target size of w50-fold. Comprehensive variant detection and analysis were
performed with various in-house established bioinformatics pipelines, and information for
different types of variations including single nucleotide variants, short insertions and dele-
tions, and copy number variations was collected. The sequence variations were crossed with
variants in the public databases to identify ethnic-specific variants. To study the impact of
sequence variations that are enriched in the Taiwanese Han population, variants that are pre-
sent in at least two exomes (i.e., minor allele frequency >9%) were further annotated. Over-
all, we detected 308 loss-of-function variants that belong to 291 genes in the Taiwanese Han
Exome Sequencing dataset. Functional annotation revealed a significant pathological influencef Molecular Medicine, College of Medicine, National Cheng Kung University, 1 University Road,
du.tw (H.S. Sun).
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134 Y.-C. Lin et al.of these loss-of-function-associated genes in the risk of various human diseases including lung
cancer. This is the first NGS (next-generation sequencing)-generating dataset to comprehen-
sively report coding sequence variants in the Taiwanese Han population. Given that the Taiwa-
nese Han population is the Han Chinese residing in Taiwan, it is normally underrepresented in
population-genetics studies. We believe the study will contribute valuable information that
will have an impact on medical as well as population genetics.
Copyright ª 2014, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
The completion of the Human Genome Project has identi-
fied an entire human reference sequence. As our knowl-
edge of this sequence grows, the need to explore the levels
of natural variation relative to this reference sequence also
increases, among individuals and between human pop-
ulations. Knowledge of DNA sequence variation among in-
dividuals plays an essential role in understanding the
genetic background of the population. In addition,
sequence information are also extremely important for
decoding the impact of genetic variationsdincluding single
nucleotide variants (SNVs), short insertions and deletions
(InDels), and copy number variations (CNVs)don complex
human diseases, conferring susceptibility or resistance, or
influencing interaction with environmental factors.
The advances of DNA sequencing technologies lead to
ultrahigh throughput detection of DNA sequence variants
and shorten the duration from years to days for finding
causal mutations in medical research. With next-generation
sequencing (NGS) technology, whole genome sequencing
(WGS) can detect DNA variants across the whole genome,
whereas whole exome sequencing (WES or exome-seq) is
focused on sequencing the protein coding exons and finding
variants in the coding regions that usually result in a direct
effect on protein functions and lead to many human dis-
eases.1e3 Compared to WGS, exome-seq is more cost-
efficient, with enough depth of coverage to identify the
variants especially in the coding regions.4 Although WGS
can discover more variants, it is currently not easy to sys-
tematically interpret the functional importance of the
“noncoding variants.” Moreover, other substantial draw-
backs of WGS, such as the need for further analysis and
storage of larger-scale data, make exome-seq currently
more practical as a promising approach in molecular di-
agnostics for diseases caused by coding region variants.5
The variant profile established by exome-seq in a spe-
cific population is of fundamental importance for investi-
gating population genetics and studying genomic medicine.
Exome-seq has been applied in several large sequencing
projects such as the 1000 Genomes Project (a collaboration
of international research teams),6,7 the National Heart,
Lung, and Blood Institute Grand Opportunity Exome
Sequencing Project,8 the National Institute of Environ-
mental Health Sciences Environmental Genome Project
(http://evs.gs.washington.edu/niehsExome/), and the
UK10K Project (http://www.uk10k.org/). These multiple
efforts indicate that elucidating the roles of coding variantsin population genomics is an ongoing processes. However,
only a limited number of ethnic populations are covered in
the large-scale exome-seq projects. Thus, several
sequencing-based studies have been carried out in specific
populations, including Danes (Denmark) and Southeast
Asian Malays, to profile genetic variations and identify
functionally important variants.9e11 These studies have
strengthened the importance of population-specific varia-
tion in the exome to public health significance in human
populations.
In this report, we applied deep exome sequencing and
systematic workflows to profile genetic variations including
SNVs, small InDels, and CNVs enriched in the coding regions
of the Taiwanese Han population. The established pipeline
is ready to be used in routine genomic study. This ethnic-
specific information of Taiwanese Han coding variants will
serve as a reference dataset to facilitate medical research
in the Han Chinese population.
Materials and methods
Samples
A total of 11 unrelated individuals belonging to the Han
Chinese population were randomly selected, and genomic
DNA samples were obtained from the Taiwan Han Chinese
Cell and Genome Bank.12 Five male and six female in-
dividuals were included, and the available demographic
information is listed in Table S1 in the supplementary ma-
terial online. The quality and quantity of each DNA sample
were calibrated using an ND-1000 spectrophotometer
(NanoDrop, Wilmington, DE, USA) to ensure adequate input
DNA for further experiments.
Library preparation, exome enrichment, and
sequencing
Three micrograms of each DNA sample was used to prepare
the fragment library for the SOLiD5500xl sequencer (Life
Technologies, Grand Island, NY, USA). Targeted exomes
were captured and enriched using the SureSelect Target
Enrichment Kit (Agilent, Santa Clara, CA, USA) or the Tar-
getSeq Exome Enrichment Kit (Life Technologies), both of
which targetedw20,000 genes covering 37e45 Mb genomic
sequences. The captured exomes were subsequently used
for emulsion polymerase chain reaction to amplify the DNA
fragments onto the beads following the protocols provided
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Technologies). Finally, the beads carrying amplified bound
DNA were modified to covalently adhere to a SOLiD-coated
slide and then processed following the sequencing pro-
cedures of the SOLiD Sequencer System according to the
manufacturer’s instructions.Read mapping
The sequencing raw data from SOLiD5500xl were first
analyzed using the SOLiD Accuracy Enhancement Tool
(SAET; Life Technologies) for color space correction.13 The
color space reads with high quality (median Phred quality
score 40) were mapped to the human reference genome
(hg19, http://genome.ucsc.edu) using the mapping algo-
rithm implemented in LifeScope Genomic Analysis Software
(Life Technologies). The mapping scheme uses both global
and local alignments to efficiently map for various read
lengths.14 The uniquely mapped reads were reported in
BAM files and subsequently used in the targeted sequencing
module in LifeScope Genomic Analysis Software (Life
Technologies) for SNV and InDel analyses, and in the
cn.MOPS package15 for CNV analysis.SNV, InDel, and CNV identification
The LifeScop software (Life Technologies) uses either a
Bayesian or Frequentist algorithm in the diBayes workflow
to find SNVs. Both algorithms consider the color quality
values, position error profiles, and probe error profiles. The
Frequentist algorithm is used to calculate the probability of
a null hypothesis that the observed valid dicolor base mis-
matches are errors. The Bayesian theorem is used to esti-
mate the posterior probability of the most likely genotype
(G) at a genome position from a list of reads (R) that are
mapped to that position and to report the genotype with
the highest likelihood.
For identification of InDels, the gap alignments con-
tained in the BAM files were used as evidence to make the
InDel calls. Using a novel split-read technique, LifeScope
Software (Life Technologies) detects up to 19 bases and 4
bases for deletion and insertion, respectively. A General
Feature Format (GFF, V3) format was produced as a final
output from small indel analysis.
To discover CNVs, the Copy Number estimation by a
Mixture Of PoissonS (cn.MOPS) package15 was used. The
cn.MOPS applied the Bayesian approach to decompose read
variations across samples into integer copy numbers and
noise by its mixture components and Poisson distributions,
respectively. Because the cn.MOPS models the depths of
coverage across samples at each genomic position, the al-
gorithm does not suffer from read count biases along
chromosomes. To accommodate the different target re-
gions enriched by SureSelect Target Enrichment Kit and
TargetSeq Exome Enrichment Kit, we crossed the bed files
and used the common regions as targets in further CNV
identification. The program was running under the default
setting (i.e., the upper and lower thresholds are 0.5 and
0.8, respectively), and the minimum number of segments
was set as equal to 1.Novel variant discovery
The resulting BAM and GFF3 files from LifeScope (Life
Technologies) were used to uncover novel variants identi-
fied in the Taiwanese Han population. The SNV and InDel
records were downloaded from dbSNP (ftp://ftp.ncbi.nih.
gov/snp/database/) and the 1000 Genomes (ftp://ftp.
1000genomes.ebi.ac.uk/vol1/ftp/) and used to compare
to the sequence variants identified in this study. In addi-
tion, information collected in the Database of Genomic
Variants (http://dgv.tcag.ca/dgv/app/home) was also
downloaded to filter out previously identified CNVs. The
variants were classified as known ones, which have been
reported in public databases, and novel ones, which are not
found in public databases.
Annotation of SNVs and InDels
The novel SNVs and InDels were next annotated using an in-
house developed pipeline with implementation of the
ANNOVAR software.16 Novel SNVs resulting in missense or
nonsense substitutions of amino acids were analyzed using
the SIFT17 and PolyPhen 2 (PPH218) computational tools to
predict the functional consequence of changed sequences.
To identify the SNVs with a potential effect on splicing, all
SNVs were annotated based on their genomic coordinates
located adjacent to a splicing junction (50 donor:
5eþ6 bp, 30 acceptor: 30e5 bp).19,20 The potential ef-
fects of identified SNVs on splicing were predicted by using
the Human Splicing Finder (http://www.umd.be/HSF3/).21
The InDels were separated into two categories: those that
are in the coding exons (downloaded from UCSC Table
Browser) and those in the splicing regions mentioned
above. Because the coding InDels may change amino acid
coding depending on the number of changed nucleotides in
the indel, we further classified them as in-frame (3n) or
frameshift (not 3n) variants.
Biological significance of potential deleterious
variants
All variants with predicted damage to the encoded protein
are classified as loss-of-function (LoF) variants. To reveal
the biological significance of these LoFs, we performed a
pathway analysis using functional Ontology Analysis module
in the MetaCore Analytical suite (GeneGo Inc., St. Joseph,
MI, USA). The probability for which mapping of the gene list
to a specific ontology would occur by chance was calculated
using the p value of hypergeometric distribution. The
significantly enriched categories at p < 0.05 indicating
significant relevance of the ontologies to the gene list are
reported in the results.
Results
Performance of exome sequencing
A total of 30 Gb of data from massively parallel sequencing
was obtained for 11 exomes of the Han Chinese population
residing in Taiwan. The medium numbers of base qualities
136 Y.-C. Lin et al.reaches to the top value of 41, and mapping qualities range
from 88.5 to 96, indicating a high-quality dataset (Fig. 1A).
Approximately 60% of the total reads uniquely mapped to
the human reference genome (Fig. 1B) and an estimated
97% of the target regions were covered by sequence reads
(Fig. 1C). Overall, more than 90% (79e95%) of the targeted
bases were covered by at least one read, and 75% (25e91%)
of the targeted bases were covered by more than five reads
(Table S1 in the supplementary material online), resulting
in an averaged enrichment of w50-fold. Further sequence
analysis on the remaining 3% of the uncovered regions
indicated that most of them were located within the 50 end
of the gene with higher GC content (data not shown).Identification of SNVs and InDels
Through the in-house developed pipelines, a total of
117,483 SNVs (Fig. 2A) and 11,533 InDels (Fig. 2B) were
identified in 11 exomes of Taiwanese individuals. The
average number of SNVs and InDels in an individual genome
was 33,846 (ranging from 13,301 to 41,485; Table S2 in the
supplementary material online) and 1989 (ranging from 494
to 3322; Table S3 in the supplementary material online),
respectively. The genomic positions, allele calls, and allele
frequencies of the common variants (i.e., found in at least
two individuals) were collected in the in-house database.
The average ratio of transition to transversion and of het-
erozygous to homozygous SNVs was 2.41 and 1.28, respec-
tively, in this exome-seq dataset, which is consistent with
previous studies (Table S4 in the supplementary material
online).22,23 In addition, the estimated heterozygote/ho-
mozygote ratio for small InDels ranged from 1.08 to 2.19
(Table S4 in the supplementary material online).
In this study, we selected common variants that were
present in at least two individuals (minor allele frequency
>9.0%) as the minimal confidence level of variant detec-
tion. This cutoff value resulted in 61,532 SNVs and 3446
InDels for further analysis. We next applied digital analysis
to confirm the presence of identified SNVs in public data-
bases. Compared to the 1000 Genomes and dbSNP,w90% of
the SNVs found in this study have been reported previously
(Table S2 in the supplementary material online). If we onlyFigure 1 The summary statistics of exome sequencing dataset.
(Mapping QV), and length of alignment (Alignment Length) of each
indicates long alignment, few mismatches, and less gapped penaltie
the reference genome (Mapped) versus that to the raw sequence
regions (On Target) among mapped target regions (Mapped) is plotfocused on the common (i.e., shared by at least 2 persons)
variants, 94% of the variants identified in this study were
shared by 1000G and dbSNP (ranging from 93% to 96%;
Fig. 2C). This number goes up to 97% if we cross-reference
with combined datasets. As for InDel annotation, 84%
(2900/3446) of the common InDels were found in the da-
tabases. In the remaining novel InDels, 61 and 227 of them
were located in the coding regions and adjacent to the
splicing junctions, respectively. Taken together, around 3%
(1960/61,532) of the SNVs were not present in either SNP
databases and classified as novel SNVs in the Taiwanese Han
population.
By using PolyPhen and SIFT predictions, we character-
ized the functional consequences on protein-coding vari-
ants identified in the analysis. Fifty-five percent (1078/
1960) of the novel SNVs were silent mutations. Among the
882 SNVs that were nonsynonymous, 170 missense and 24
nonsense SNVs in 181 genes were predicted to damage the
encoded proteins (Fig. 2D). In addition, we identified 69%
(42/61) of the novel InDels causing the frameshift of the
amino acid coding, which may lead to a damage effect on
the encoded proteins (Fig. 2E). Based on the genomic co-
ordinates adjacent to a splicing junctions, we found that
w10% (194/1960; minor allele frequency, 0.09e0.41) of the
novel SNVs are located in regions where they may have
splicing effects. Further analysis using the Human Splicing
Finder21 predicted that 21% (40/194) of them may poten-
tially affect splicing events.Detection of CNVs
As the cn.MOPS calls CNVs depending on the depths of
coverage across samples at each genomic position, it is
important to remove read variations and noise across
samples. Using a modified cn.MOPS pipeline (Fig. 3A), our
data demonstrated that Poisson normalization was able to
effectively remove the read variations and noise across
samples and significantly improved overall read quality
(Fig. 3B and C and Fig. S1A and B in the supplementary
material online). As the read features after normalization
differ significantly from the other samples (data not
shown), exome sequencing data from sample 11 was(A) Median qualities of base (Base QV), mapping alignments
sample are plotted on the Y axis. The high Mapping QV (>90%)
s. (B) For each sample, the percentage of the reads that map to
reads (Total) is shown. (C) The proportion of coverage target
ted for each sample.
Figure 2 The workflows and summaries of identified SNVs and InDels. (A) In-house developed analytic workflows for novel SNV
identification. (B) In-house developed analytic workflows for novel InDel identification. (C) Summary of the numbers and pro-
portions of the common coding SNVs in Taiwanese population. (D) The number and classification of SNVs. (E) The length distribution
of the novel InDels is shown. InDels Z insertions and deletions; SNVs Z single nucleotide variants.
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exomes, information for the regions, lengths, and types of
CNVs (deletion, amplification, and mixed deletion/ampli-
fication) in each exome was collected and analyzed. Among
thew160,000 commonly enriched regions, we found a total
of 2525 CNV regions (size range, 0.1e5.3 Mb), accounting
for 82.4 Mb in 10 exomes. On average, each exome had 323
CNVs, and there were 489 common CNVs identified in at
least two exomes (Table S5 in the supplementary material
online). The distribution of identified common CNVs along
the chromosomes is given in Fig. 3D. Approximately 87%
(427/489) of the CNV regions detected in our study over-
lapped with CNVs currently annotated in a public database
(http://projects.tcag.ca/variation/).24 In addition, regions
of 22 reported CNVs overlapped with those previously
identified in the Han Chinese population in Taiwan using
SNP microarray technology.25 Crossed with genome co-
ordinates, 62 novel CNVs covering 71 functional genes were
identified in our Exome dataset.Biological impact of novel LoF variants
Overall, we detected 308 LoF variants representing 291
genes in the Taiwanese Han Exome Sequencing dataset.
These variants occur in two to nine samples with allelefrequency ranging from 9% to 64%. Although the majority of
the LoFs are present as heterozygote, 11.4% (35/308) of the
LoFs were found as homozygote in a few individuals. To
further illustrate the functional impact of these common
and novel LoF variants, variant-associated genes were
crossed with the OMIM (Online Mendelian Inheritance in
Man) database and analyzed using the Enrichment analysis
workflow in the MetaCore software (GeneGo Inc.) suite to
identify the significantly overrepresentative diseases.
Among the 291 variant-associated genes, 207 genes are
collected in the OMIM database, and 49 genes are actually
associated with various known human diseases (Table 1).
Furthermore, the enrichment analysis identified that 76% of
the top 50 diseases significantly enriched in LoF-associated
genes are various types of cancers, including skin (minimal
p Z 3.947Ee08) and lung (minimal p Z 3.064Ee04) neo-
plasms (Fig. S2 in the supplementary material online). The
top 10 cancers with the greatest number of matched genes
in disease biomarkers are given in Table 2. Among them,
82.1% (239 nonredundant genes) of the total LoF-associated
genes matched with lung cancer disease biomarkers, fol-
lowed by endometrial neoplasms (109 nonredundant genes)
and colorectal neoplasms (66 nonredundant genes). Further
classification of matched lung cancer biomarkers by “Ob-
ject type” revealed that roughly two-thirds (184/239) of
the identified objects function as binding proteins or
Figure 3 The workflow and summary of identified exome copy number variations (CNVs). (A) CNV analytic workflow. (B) The
scatter plots and (C) histograms of reads after normalization demonstrate the approximately constant variation of read depth
among samples. The X and Y axes of the histograms are the depths and counts of reads in each exome sequencing data, respec-
tively. The X and Y axes of the scatter plots are the comparison of read depths between two samples. (D) Manhattan plot shows the
identified CNVs across 10 Taiwanese exomes. The target regions along the chromosomes are plotted at the X axis and the fre-
quencies of CNVs found in this study are shown at the Y axis. The positive (red color) and negative values (green color) indicate gain
and loss of copy number at given regions, respectively.
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DNA, RNA, proteins), thereby suggesting a broad spectrum
of “regulatory network” effect (Table 3). Taken together,
the high percentage of LoF-associated genes matching to
cancer biomarkers suggests that the genetic background
may contribute a significant part of the risk for certain
diseases in Taiwan.Discussion
NGS technology has greatly facilitated our efforts to un-
cover the genomic variants in a high-throughput, time-
saving, and cost-effective fashion. As the majority ofdisease-causing mutations are found in the coding regions,
screening sequence variants enriched in the targeted
exome is usually relatively efficient in finding the direct
effects on protein function and discovering the causal
mutations of diseases. The consistent results of common
SNVs between our analysis and the 1000 Genomes/dbSNP
indicated the completeness and considerable efficiency of
surveying the human genome using exome-seq. Through our
analyses, several hundreds of novel variants were identified
in the Taiwanese Han population that potentially play roles
in the pathogenesis of specific diseases in Taiwan. To the
best of our knowledge, this is the first NGS-generating
dataset to report various types of sequence variants in the
Taiwanese Han population. Given that the Taiwanese Han
Table 1 LoF-associated genes with known human diseases (annotated with OMIM).
Gene symbol Variant typea Zygosity (Het.; Homo.)b Freq. %c OMIM/Diseased
POLH CNV ND 18 603968/Xeroderma pigmentosum, Variant
type; XPV
KL CNV ND 18 604824/Tumoral calcinosis,
hyperphosphatemic, familial; HFTCj Klotho; KL
SKIV2L SNV 2; 0 9 600478/Trichohepatoenteric syndrome 2;
THES2
ATP2B3 SNV 5; 0 23 300014/Spinocerebellar ataxia, X-linked 1;
SCAX1
OFD1 InDel 2; 0 9 300170/SimpsoneGolabieBehmel syndrome,
Type 2j Joubert syndrome 10; JBTS10j
orofaciodigital syndrome I; OFD1
ATR InDel 2; 0 9 601215/Seckel syndrome 1; SCKL1j Cutaneous
telangiectasia and cancer syndrome, familial;
FCTCS
IGFBP7 SNV 3; 0 14 602867/Retinal arterial macroaneurysm with
supravalvular pulmonic stenosis
SMAD1 SNV 2; 0 9 601595/Pulmonary hypertension, primary, 1;
PPH1
RGS9 CNV ND 18 604067/PRolonged electroretinal response
suppression; PERRS
RARS2 CNV ND 18 611524/Pontocerebellar hypoplasia, Type 6;
PCH6
PKD1 SNV 1; 1 14 601313/Polycystic kidney disease 1; PKD1
CD36 InDel 2; 0 9 173510/Plasmodium falciparum blood
infection levelj Platelet glycoprotein IV
deficiencyj Coronary heart disease,
Susceptibility to, 7; CHDS7j Malaria,
Susceptibility to
LRRK2 SNV 2; 0 9 609007/Parkinson disease, late-onset; PDj
Parkinson disease 8, autosomal dominant;
PARK8
MYH7 SNV 2; 0 9 160760/Myopathy, distal, 1; MPD1j
Scapuloperoneal myopathy, MYH7-related;
SPMMj Cardiomyopathy, familial hypertrophic,
1; CMH1j Myopathy, myosin storagej
Cardiomyopathy, dilated, 1S; CMD1S
PIGN SNV 2; 0 9 606097/Multiple congenital anomalies-
hypotonia-seizures syndrome 1; MCAHS1
CEP135 CNV ND 18 611423/Microcephaly 8, primary, autosomal
recessive; MCPH8
ASPM SNV 2; 0 9 605481/Microcephaly 5, primary, autosomal
recessive; MCPH5
HCFC1 SNV 2; 0 9 300019/Mental retardation, X-linked 3; MRX3
POLR3B CNV ND 18 614366/Leukodystrophy, hypomyelinating, 8,
with or without oligodontia and/or
SALL4 SNV 2; 0 9 607343/Ivic syndromej Duane-radial ray
syndrome; DRRS
THBS2 SNV 2; 0 9 188061/Intervertebral disc disease; IDD
FLG InDel 0; 2 18 135940/Ichthyosis vulgarisj dermatitis, atopic,
2; ATOD2
UNC93B1 SNV 2; 0 9 608204/Herpes simplex encephalitis,
Susceptibility to, 1
MET SNV 3; 0 14 164860/Hepatocellular carcinomaj Renal cell
carcinoma, papillary, 1; RCCP1
CD46 CNV ND 18 120920/Hemolytic uremic syndrome, atypical,
Susceptibility to, 2; AHUS2
(continued on next page)
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Table 1 (continued)
Gene symbol Variant typea Zygosity (Het.; Homo.)b Freq. %c OMIM/Diseased
STAT5B CNV ND 27 604260/Growth hormone insensitivity with
immunodeficiency
GLB1 SNV 2; 0 9 611458/GM1-Gangliosidosis, Type Ij GM1-
gangliosidosis, Type IIj GM1-Gangliosidosis,
Type IIIj Mucopolysaccharidosis Type IVB
FN1 SNV 2; 0 9 135600/Glomerulopathy with fibronectin
deposits 2; GFND2
ABCB4 SNV 2; 0 9 171060/Gallbladder disease 1; GBD1j
Cholestasis, progressive familial intrahepatic,
3; PFIC3j Cholestasis, intrahepatic, of
pregnancy 3; ICP3
FRA10AC1 SNV 4; 0 18 608866/Fragile site, folic acid-type, rare,
FRA(10)(q23.3), candidate gene
MYO1E SNV 1; 1 14 601479/Focal segmental glomerulosclerosis 6;
FSGS6
ENPP1 SNV 2; 0 9 173335/Diabetes mellitus, noninsulin-
dependent; NIDDMj Arterial calcification,
generalized, of infancy, 1; GACI1j Ossification
of the posterior longitudinal ligament of spine;
OPLLj Hypophosphatemic rickets, autosomal
recessive, 2; ARHR2
MYO3A SNV, CNV 2; 0, ND 9, 18 606808/DEAFNESS, AUTOSOMAL RECESSIVE 30;
DFNB30
RDX CNV ND 18 179410/Deafness, autosomal recessive 24;
DFNB24
GFM1 SNV 2; 0 9 606639/Combined oxidative phosphorylation
deficiency 1; COXPD1
DNAH5 SNV 2; 0 9 603335/Ciliary dyskinesia, primary, 1; CILD1j
Ciliary dyskinesia, primary, 3; CILD3
ABCB11 SNV 2; 0 9 603201/Cholestasis, progressive familial
intrahepatic, 2; PFIC2j Cholestasis, benign
recurrent intrahepatic, 2; BRIC2
TDRD7 CNV ND 64 611258/Cataract 36; CTRCT36
COL1A1 SNV 2; 0 9 120150/Caffey diseasej EhlerseDanlos
syndrome, Type Ij EhlerseDanlos syndrome,
Type VII, autosomal dominantj Osteogenesis
imperfecta, Type Ij Osteogenesis imperfecta,
Type IIj Osteogenesis imperfecta, Type IVj
Osteoporosisj Osteogenesis imperfecta, Type
IIIj Dermatofibrosarcoma protuberans; DFSP
ATP2A1 SNV 2; 0 9 108730/Brody myopathy
PRDM5 SNV 1; 1 14 614161/Brittle cornea syndrome 2; BCS2
BBS7 CNV ND 18 607590/BardeteBiedl syndrome; BBS
CTLA4 CNV ND 18 123890/Autoimmune diseasej Systemic lupus
erythematosus; SLEj Diabetes mellitus, insulin-
dependent, 12; IDDM12j Celiac disease,
Susceptibility To, 3; CELIAC3j Hepatitis B virus,
Susceptibility to
COL4A3 CNV ND 45 120070/Alport syndrome, autosomal dominantj
Hematuria, benign familial; BFHj Alport
syndrome, autosomal recessive
RNASEH2A CNV ND 18 606034/AicardieGoutieres syndrome 4; AGS4
BTK SNV 3; 0 14 300300/Agammaglobulinemia, X-linked; XLAj
Isolated growth hormone deficiency, Type III;
IGHD3
ABCD1 SNV 2; 0 9 300371/Adrenoleukodystrophy; ALD
(continued on next page)
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Table 1 (continued )
Gene symbol Variant typea Zygosity (Het.; Homo.)b Freq. %c OMIM/Diseased
TRIP11 SNV 2; 0 9 604505/Achondrogenesis, Type IA; ACG1A
NR0B1 SNV 2; 0 9 300473/46,XY sex reversal 2; SRXY2j Adrenal
hypoplasia, congenital; AHC
a Variant type: CNV Z copy number variation; InDel Z insertion and deletion; SNV Z single nucleotide variant.
b Zygosity: Het. Z heterozygote; Homo. Z homozygote; ND Z not determined.
c Freq. %: allele frequency of SNV, InDel, and CNV.
d OMIM/disease: OMIM (Online Mendelian Inheritance in Man) number and associated diseases.
Exome-Seq profile in Taiwanese population 141population is the Han Chinese residing in Taiwan, this group
is normally underrepresented in population-genetics
studies. We believe that this information will have a
major impact on medical as well as population genetics
studies conducted in this specific population group. The
information presented in here is publicly available for other
researchers upon request.
LoF variants existing in the general population have
been reported in previous studies with an estimated range
between 200 LoFs and 800 LoFs per human genome.26e28
Even when stringent filtering processes are applied, the
average number of LoFs still reaches up to 100, withw20 of
them in the homozygous state, in the general population.26
Nevertheless, the majority of these deleterious variants are
recessive and existing in low frequencies owing to natural
selection.9 That is, the general population believes that the
rare LoF variants are where most of the action is in terms of
effects on disease risk; thus, current studies have been
emphasizing the importance of rare variants in populations
contributing to disease risk.29,30 By contrast, this study
focused on the common but potentially damaging variants
(i.e., missense/nonsense, frameshift InDels, and CNVs) and
found w300 novel LoF variants that are specific and
enriched in the Taiwanese Han population. Common LoF
variants may have resulted from positive selection among
themselves or may have hitchhiked to a high frequency
along with some other variants that were selected.26
Alternatively, the functions of high frequency LoF-
associated genes may be evolutionarily poorly conserved
and are highly redundant.26 In any case, common LoFs
provide important information that help us understand the
changes that accompanied modern human heritage and
later development. Nevertheless, a previous study hasTable 2 Top 10 cancers with the greatest number of LoF-assoc
Diseases Total in disease Total in datas
1 Lung neoplasms 17,011 291
2 Endometrial neoplasms 10,229 209
3 Colorectal neoplasms 9397 203
4 Breast neoplasms 9088 185
5 Rectal neoplasms 6665 151
6 Urinary bladder neoplasms 4772 122
7 Glioma 5184 119
8 Skin neoplasms 4483 116
9 Mouth neoplasms 4289 109
10 Melanoma 3885 92
CNV Z copy number variation; InDel Z insertion and deletion; LoF Zshown that a common single variant with a rather small
effect but moderate frequency accounts for 21% of all cases
in type 2 diabetes.31 In the current study, functional
annotation of genes with deleterious variants revealed that
these genes are enriched in many types of neoplasms and
human diseases. As w17% (49/291) of the novel variant-
associated genes identified in this study have been linked
to various known human diseases, these results suggest that
common susceptibility alleles may contribute dispropor-
tionately to the population risk for a disease, thus meriting
special attention.
Lung cancer is the leading cause of cancer deaths
worldwide, including the United States (for review, see
Subramanian and Govindan32) and Taiwan. Although ciga-
rette smoking is considered to be the most important risk
factor for lung cancer, it was estimated that 10e30% of lung
cancers occur in patients who are nonsmokers.33 In Taiwan,
cigarette smoking accounts for only 50% of lung cancer
incidence, and more than 90% of Taiwanese women are
nonsmokers.34 Moreover, the sex discrepancy in lung cancer
mortality in Taiwan (male/female ratio, 2:1) was lower
than that of other areas of the world, where the ratio
ranged from 2.3 to 8.6. Thus, it was suggested that factors
other than cigarette smoking may be associated with the
development of lung cancer in Taiwan.34 Although a num-
ber of risk factors including cooking oil vapor35 and human
papillomavirus infection36 have been identified for lung
cancer among nonsmoking women in Taiwan, the etiology
of lung cancer for nonsmokers remains largely unknown.
Recent studies have shown that genetic predisposition plays
an important role in lung cancer by increasing the in-
dividual’s susceptibility to environmental carcinogens.37
Significant associations of gene polymorphisms includingiated genes matched to disease biomarkers.
et SNV p InDel p CNV p
180 3.064Ee04 40 2.568Ee01 71 5.763Ee03
129 3.304Ee06 26 2.003Ee01 54 1.059Ee04
124 4.605Ee07 27 4.769Ee02 52 4.251Ee05
120 9.641Ee07 24 1.580Ee01 41 4.499Ee02
90 4.151Ee05 19 1.196Ee01 42 2.569Ee05
76 5.646Ee07 16 4.649Ee02 30 8.950Ee04
69 9.164Ee04 18 2.396Ee02 32 7.503Ee04
76 3.947Ee08 12 2.766Ee01 28 1.622Ee03
68 3.758Ee06 11 3.435Ee01 30 1.312Ee04
58 1.525Ee04 12 1.367Ee01 22 1.887Ee02
loss-of-function; SNV Z single nucleotide variant.
Table 3 Functional classification of loss-of-function
(LoF)-associated biomarkers in lung neoplasm.
Object type Number of objects
Enzyme 22
Kinase 10
Phosphatase 3
Protease 9
Protein/Glycoprotein/RNA 33
Regulator 184
Transcription factor 12
Receptor 23
Channel/Transporter 48
Binding proteins 97
Regulator (GDI, GAP, GEF) 4
142 Y.-C. Lin et al.p53 codon 7238 and XPD codons 751 and 31239 with lung
cancer risk have been reported. It is noteworthy that 82.1%
(239/291) of LoF-associated genes identified in the Taiwa-
nese Han population matched with the disease biomarkers
of lung neoplasm. Although there is no well-known tumor-
associated genes on the list, the majority of these matched
lung cancer biomarkers functionally belong to the broad
groups that were previously classified as oncogenes40 or
tumor suppressors.41,42 The exact effect of these LoF-
associated genes on lung cancer tumorigenesis requires
further study and is currently under investigation. Never-
theless, the high proportion of LoF-associated genes
matching to many disease biomarkers suggests that genetic
background may contribute a significant part of the risk for
certain diseases in Taiwan.
In conclusion, the results from our study established the
genetic profile of coding regions and provided the refer-
ence dataset in the Taiwanese population to single-base
resolution. As this is the first NGS-generating dataset to
comprehensively report coding sequence variants in the
Taiwanese Han population, we believe the study will
contribute valuable information to future molecular medi-
cine in the postgenomic era in Taiwan.
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